摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,3-Di-pyridin-2-yl-acrylic acid ethyl ester | 246514-20-5

中文名称
——
中文别名
——
英文名称
3,3-Di-pyridin-2-yl-acrylic acid ethyl ester
英文别名
Ethyl 3,3-dipyridin-2-ylprop-2-enoate
3,3-Di-pyridin-2-yl-acrylic acid ethyl ester化学式
CAS
246514-20-5
化学式
C15H14N2O2
mdl
——
分子量
254.288
InChiKey
LHUUFEWUCLJDIM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    19
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    52.1
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    3,3-Di-pyridin-2-yl-acrylic acid ethyl ester 在 sodium tetrahydroborate 、 lithium aluminium tetrahydride 、 nickel dichloride 作用下, 以 四氢呋喃乙醇 为溶剂, 反应 6.0h, 生成 3,3-dipyridylpropanol
    参考文献:
    名称:
    Structure–activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels
    摘要:
    Cilnidipine is a 1,4-dihydropyridine derived L/N-type calcium channel dual blocker possessing neuroprotective and analgesic effects which are related to its N-type calcium channel inhibitory activity. In order to find specific N-type calcium channel blockers with the least effects on cardiovascular system, we performed structure-activity relationship study on APJ2708, which is a derivative of cilnidipine, and found a promising N-type calcium channel blocker 21b possessing analgesic effect in vivo with a 1600-fold lower activity against L-type calcium channels than that of cilnidipine. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.11.021
  • 作为产物:
    描述:
    2-二吡啶基酮磷酰基乙酸三乙酯 在 sodium hydride 作用下, 以 乙醇 为溶剂, 生成 3,3-Di-pyridin-2-yl-acrylic acid ethyl ester
    参考文献:
    名称:
    Structure–activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels
    摘要:
    Cilnidipine is a 1,4-dihydropyridine derived L/N-type calcium channel dual blocker possessing neuroprotective and analgesic effects which are related to its N-type calcium channel inhibitory activity. In order to find specific N-type calcium channel blockers with the least effects on cardiovascular system, we performed structure-activity relationship study on APJ2708, which is a derivative of cilnidipine, and found a promising N-type calcium channel blocker 21b possessing analgesic effect in vivo with a 1600-fold lower activity against L-type calcium channels than that of cilnidipine. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.11.021
点击查看最新优质反应信息

文献信息

  • Structure–activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels
    作者:Takashi Yamamoto、Seiji Niwa、Seiji Ohno、Tomoyuki Onishi、Hiroyuki Matsueda、Hajime Koganei、Hisayuki Uneyama、Shin-ichi Fujita、Tomoko Takeda、Morikazu Kito、Yukitsugu Ono、Yuki Saitou、Akira Takahara、Seinosuke Iwata、Masataka Shoji
    DOI:10.1016/j.bmcl.2005.11.021
    日期:2006.2
    Cilnidipine is a 1,4-dihydropyridine derived L/N-type calcium channel dual blocker possessing neuroprotective and analgesic effects which are related to its N-type calcium channel inhibitory activity. In order to find specific N-type calcium channel blockers with the least effects on cardiovascular system, we performed structure-activity relationship study on APJ2708, which is a derivative of cilnidipine, and found a promising N-type calcium channel blocker 21b possessing analgesic effect in vivo with a 1600-fold lower activity against L-type calcium channels than that of cilnidipine. (c) 2005 Elsevier Ltd. All rights reserved.
查看更多